References

  1. Batsa S, Celliera C, Samahad E, Laurent-Puiga P, Lecuruabcf F. Lynch syndrome: Towards a multidisciplinary management of tumour screening. Gyn Obst Fert. 2011;39(5):269-273. PubMed | Google Scholar

  2. Ferron M, Praz F, Pocard M. The genetics of colorectal cancer. Ann Chir. 2005;130(10):602-607. PubMed | Google Scholar

  3. Blanchard JM. Des oncogènes aux régulateurs de la mitose : un changement de perspective dans notre vision des processus cancéreux. Med Sci. 2003;19(2):187-99. PubMed | Google Scholar

  4. Frebourg T, Mauillon J, Thomas G, Olschwang S. Le cancer colorectal héréditaire non polyposique: définition, génétique, diagnostic et surveillance médicale. Gastroenterol Clin Biol. 2003;27(8-9):708-14. PubMed | Google Scholar

  5. Guttmacher AE, Collins FS. Hereditary colorectal cancer. N Engl J Med. 2003;348: 919-32. Google Scholar

  6. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004;96(4): 261-8. PubMed | Google Scholar

  7. Vasen H, Mecklin J, Khan P, Lynch H. The International Collaborative Group on HNPCC. Anticancer Res. 1994;14(4B):1661-4. PubMed | Google Scholar

  8. Quehenberger F, Vasen H, van Houwelingen H. Risk of colorectal and endometrial cancer for carriers of mutations of hMLH1 and hMSH2 gene: correction for ascertainement. J Med Genet. 2005;42(6): 491-6. PubMed | Google Scholar

  9. Geiersbach KB, Wade Samowitz S. Microsatellite Instability and Colorectal Cancer. Arch Pathol Lab Med. 2011;135(10):1269-1277. PubMed | Google Scholar

  10. Parc Y, Boisson C, Thomas G, Olschwang S. Cancer risk in 348 French MSH2 or MLH1 gene carriers. J Med Genet. 2003;40(3):208-13. PubMed | Google Scholar

  11. Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroentero. 2000; 118(5):829-34. PubMed | Google Scholar

  12. Weber T. Clinical surveillance recommendation adopted for HNPCC. 348th.ed. Lancet 2006; 348:465. PubMed | Google Scholar

  13. Olschwang et al. Identification et prise en charge du syndrome HNPCC, prédisposition héréditaire aux cancers du côlon, du rectum et de l’utérus. Bul Can. 2004;91(4): 303-15. PubMed | Google Scholar

  14. Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J, Wang F, Bandipalliam P, Syngal S, Gruber SB. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroentero. 2009;137(5):1621-7. PubMed | Google Scholar